Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|December 17, 2019
[Successful treatment with recombinant thrombomodulin in transplant-associated thrombotic microangiopathy following HLA-haploidentical transplantation]Yasuyuki Otsuka, Tadakazu Kondo, Ryosuke Nomura, et al.
Cancer Science|October 16, 2020
Programmed cell death 1-expressing CD56-negative natural killer (NK) cell expansion is a hallmark of chronic NK cell activation during dasatinib treatmentKen-Ichi Ishiyama, Toshio Kitawaki, Yasuyuki Otsuka, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|December 6, 2021
[Treatment for acute leukemia showing PCR-positivity of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) at initial diagnosis: a case report and review of literature]Takashi Onaka, Yasuyuki Otsuka, Naoto Miyakawa, et al.
Cancer Science|August 27, 2021
The EZH2 inhibitor tazemetostat upregulates the expression of CCL17/TARC in B-cell lymphoma and enhances T-cell recruitmentHepei Yuan, Momoko Nishikori, Yasuyuki Otsuka, et al.
Genes, Chromosomes & Cancer|April 30, 2020
Establishment and characterization of a MALT lymphoma cell line carrying an API2-MALT1 translocationKiyotaka Izumi, Momoko Nishikori, Hepei Yuan, et al.
Ejhaem|July 18, 2022
Relapse of follicular lymphoma arising from a non-t(14;18) cloneYasuyuki Otsuka, Momoko Nishikori, Masakazu Fujimoto, et al.
Molecular Immunology|January 22, 2020
EZH2 inhibitors restore epigenetically silenced CD58 expression in B-cell lymphomasYasuyuki Otsuka, Momoko Nishikori, Hiroshi Arima, et al.
Clinical Case Reports|April 12, 2017
Persistence of a t(11;14)-positive clone in a patient with mantle cell lymphoma for 20 yearsYasuyuki Otsuka, Momoko Nishikori, Toshiyuki Kitano, et al.
Blood Advances|September 15, 2018
B cells with aberrant activation of Notch1 signaling promote Treg and Th2 cell-dominant T-cell responses via IL-33Hiroshi Arima, Momoko Nishikori, Yasuyuki Otsuka, et al.
Modern Rheumatology Case Reports|April 2, 2022
Allogeneic stem cell transplantation for trisomy 8-positive myelodysplastic syndrome or myelodysplastic/myeloproliferative disease with refractory Behçet's disease: Case report and the review of literatureTakashi Onaka, Kazuhisa Nakano, Yuri Uemoto, et al.
Pageof 2